［3］ Rong Y, Serrano M,Sluter J,et al. Analysis of p16 INK4a and its interaction with CDK4［J］.Biochem Biophys Res Commun,1996,218:254-258.
［4］ Krazke RA,Otterson GA,Lincoln CE,et al. Immunohistichemical analysis of the p16 INK4 cyclin-dependent kinases inhibator in malignant mesothelioma［J］.J Natl Cancer Inst.1995,87:1870-1874.
［5］ Liu Q, Yan YX, McClure M, et al. MTS-1(CDKN2)tumor suppressor gene deletions are a frequent event in esophagus squmous carcinoma and pancreatic adenocarcinoma cell lines［J］.Oncogene,1995,10:619-622.
［6］ Mori T, Miura K,Aoki T,et al. Frequent somic mutation of the MIS1/CDK4I(multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophagus squamous cell carcinoma［J］.Cancer Res,1994,56:3396-3399.
［7］ Okamoto A,Demetrick DJ, Spillare EA, et al. Mutation and altered expression of p16INK4 in human cancer［J］.Proc Natl Acad Sci USA.1994，91：11345-11348.
收稿日期：1999-11-19
